Utah Code § 26B-4-212: Institutional review board -- Approved study of cannabis, a cannabinoid product, or an expanded cannabinoid product.

(1) As used in this section:

(a) "Approved study" means a medical research study:

(i) the purpose of which is to investigate the medical benefits and risks of cannabinoid products; and

(ii) that is approved by an IRB.

(b) "Cannabinoid product" means the same as that term is defined in Section 58-37-403.

(c) "Cannabis" means the same as that term is defined in Section 58-37-403.

(d) "Expanded cannabinoid product" means the same as that term is defined in Section 58-37-403.

(e) "Institutional review board" or "IRB" means an institutional review board that is registered for human subject research by the United States Department of Health and Human Services.

(2) A person conducting an approved study may, for the purposes of the study:

(a) process a cannabinoid product or an expanded cannabinoid product;

(b) possess a cannabinoid product or an expanded cannabinoid product; and

(c) administer a cannabinoid product, or an expanded cannabinoid product to an individual in accordance with the approved study.

(3) A person conducting an approved study may:

(a) import cannabis, a cannabinoid product, or an expanded cannabinoid product from another state if:

(i) the importation complies with federal law; and

(ii) the person uses the cannabis, cannabinoid product, or expanded cannabinoid product in accordance with the approved study; or

(b) obtain cannabis, a cannabinoid product, or an expanded cannabinoid product from the National Institute on Drug Abuse.

(4) A person conducting an approved study may distribute cannabis, a cannabinoid product, or an expanded cannabinoid product outside the state if:

(a) the distribution complies with federal law; and

(b) the distribution is for the purposes of, and in accordance with, the approved study.